The 16 Fellows are highly accomplished professionals working in the healthcare
product regulatory field. They were honored during the opening session of the 2009 RAPS Annual
Conference & Exhibition in Philadelphia.
The RAPS Fellows program recognizes senior regulatory professionals for their continued significant
contributions and leadership in the advancement of the profession and the professional. Fellows
receive a dignified status and special services from RAPS and will serve as important resources for
strategic dialogue, mentoring, implementation of special initiatives and international development.
This is the second year of the RAPS Fellows program.
The 2009 RAPS Fellows are:
Chas Burr, MS, MBA, graduate program director, Health Product Regulation, Regis College; and president and principal consultant, Chas Burr Q/R Services Inc.
Joy Cavagnaro, PhD, DABT, RAC, president and founder, Access BIO
Nancy Chew, MS, RAC, president, Regulatory Affairs, North America Inc.
Michael Hamrell, PhD, RAC, president, MORIAH Consultants
Marie D. Kuker, RPh, RAC, president, Kuker Regulatory Consulting LLC
Philip T. Lavin, PhD, executive chairman, Averion International
Kenneth F. Miles, PhD, RAC, principal consultant, Miles Technologies Group LLC
Penny Northcutt, RAC, CQA, president and CEO, REGSolutions LLC
Peggy Pence, PhD, RAC, president and executive officer, Symbion Research International Inc.
Kathryn Rangus, MS, MBA, RAC, president, Drug & Device Regulatory Services Inc.
Robert Schiff, MS, PhD, RAC, CQA, president and CEO, Schiff & Company Inc.
David C. Steinberg, MBA, president, Steinberg & Associates Inc.
Susan Stewart, RAC, vice president, regulatory affairs, TransMolecular Inc.
O. Reed Tarwater, PhD, RAC, director, pharmaceutical consulting services, Anson Group
Henrietta Ukwu, MD, FACP, vice president, global regulatory affairs, Wyeth Pharmaceuticals
Pamela Williamson, MBA, RAC, senior vice president, global regulatory affairs and corporate quality, Genzyme Corporation
product regulatory field. They were honored during the opening session of the 2009 RAPS Annual
Conference & Exhibition in Philadelphia.
The RAPS Fellows program recognizes senior regulatory professionals for their continued significant
contributions and leadership in the advancement of the profession and the professional. Fellows
receive a dignified status and special services from RAPS and will serve as important resources for
strategic dialogue, mentoring, implementation of special initiatives and international development.
This is the second year of the RAPS Fellows program.
The 2009 RAPS Fellows are:
Chas Burr, MS, MBA, graduate program director, Health Product Regulation, Regis College; and president and principal consultant, Chas Burr Q/R Services Inc.
Joy Cavagnaro, PhD, DABT, RAC, president and founder, Access BIO
Nancy Chew, MS, RAC, president, Regulatory Affairs, North America Inc.
Michael Hamrell, PhD, RAC, president, MORIAH Consultants
Marie D. Kuker, RPh, RAC, president, Kuker Regulatory Consulting LLC
Philip T. Lavin, PhD, executive chairman, Averion International
Kenneth F. Miles, PhD, RAC, principal consultant, Miles Technologies Group LLC
Penny Northcutt, RAC, CQA, president and CEO, REGSolutions LLC
Peggy Pence, PhD, RAC, president and executive officer, Symbion Research International Inc.
Kathryn Rangus, MS, MBA, RAC, president, Drug & Device Regulatory Services Inc.
Robert Schiff, MS, PhD, RAC, CQA, president and CEO, Schiff & Company Inc.
David C. Steinberg, MBA, president, Steinberg & Associates Inc.
Susan Stewart, RAC, vice president, regulatory affairs, TransMolecular Inc.
O. Reed Tarwater, PhD, RAC, director, pharmaceutical consulting services, Anson Group
Henrietta Ukwu, MD, FACP, vice president, global regulatory affairs, Wyeth Pharmaceuticals
Pamela Williamson, MBA, RAC, senior vice president, global regulatory affairs and corporate quality, Genzyme Corporation
Companies in this article
